Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The risk of venous thromboembolism in patients with multiple sclerosis: the Clinical Practice Research Datalink
Paul J.H.L. Peeters, Marloes T. Bazelier, Bernard M.J. Uitdehaag, et al.
Journal of Thrombosis and Haemostasis (2014) Vol. 12, Iss. 4, pp. 444-451
Closed Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Inflammation as a cause of venous thromboembolism
Amene Saghazadeh, Nima Rezaei
Critical Reviews in Oncology/Hematology (2016) Vol. 99, pp. 272-285
Closed Access | Times Cited: 97
Incidence of First Stroke in Pregnant and Nonpregnant Women of Childbearing Age: A Population‐Based Cohort Study From England
Lu Ban, Nikola Sprigg, Alyshah Abdul Sultan, et al.
Journal of the American Heart Association (2017) Vol. 6, Iss. 4
Open Access | Times Cited: 68
Multiple sclerosis clinical course and cardiovascular disease risk – Swedish cohort study
Homayoun Roshanisefat, Shahram Bahmanyar, Jan Hillert, et al.
European Journal of Neurology (2014) Vol. 21, Iss. 11, pp. 1353-1353
Closed Access | Times Cited: 65
Intravenous immune globulin and thromboembolic adverse events: A systematic review and meta‐analysis of RCTs
Eric M. Ammann, Cole Haskins, Kelsey M. Fillman, et al.
American Journal of Hematology (2016) Vol. 91, Iss. 6, pp. 594-605
Open Access | Times Cited: 56
Contraception for women with multiple sclerosis: Guidance for healthcare providers
Maria K. Houtchens, Lauren B. Zapata, Kathryn M. Curtis, et al.
Multiple Sclerosis Journal (2017) Vol. 23, Iss. 6, pp. 757-764
Open Access | Times Cited: 53
Metformin as a Potential Agent in the Treatment of Multiple Sclerosis
Angela Dziedzic, Joanna Saluk, Elżbieta Miller, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 5957-5957
Open Access | Times Cited: 48
Glucocorticoid use and risk of first and recurrent venous thromboembolism: self‐controlled case‐series and cohort study
Fernanda Andrade Orsi, Willem M. Lijfering, Geert‐Jan Geersing, et al.
British Journal of Haematology (2021) Vol. 193, Iss. 6, pp. 1194-1202
Open Access | Times Cited: 35
Association of multiple sclerosis with stroke: A comprehensive review
Mohammed Dheyaa Marsool Marsool, Priyadarshi Prajjwal, Jobby John, et al.
Health Science Reports (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 6
Asthma and chronic obstructive pulmonary disease (COPD) in people with multiple sclerosis: A systematic review and meta-analysis
Hamed Ghoshouni, Nazanin Rafiei, Mohammad Yazdan Panah, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 85, pp. 105546-105546
Closed Access | Times Cited: 6
Pro-Thrombotic Activity of Blood Platelets in Multiple Sclerosis
Joanna Saluk, Angela Dziedzic, Michał Bijak
Cells (2019) Vol. 8, Iss. 2, pp. 110-110
Open Access | Times Cited: 39
Incident cardiovascular disease in patients diagnosed with multiple sclerosis: A multi-database study
Rebecca Persson, Sally Lee, Marianne Ulcickas Yood, et al.
Multiple Sclerosis and Related Disorders (2019) Vol. 37, pp. 101423-101423
Open Access | Times Cited: 38
Pharmacological targeting of coagulation factor XI attenuates experimental autoimmune encephalomyelitis in mice
Tia C. L. Kohs, Meghan E. Fallon, E. Oseas, et al.
Metabolic Brain Disease (2023) Vol. 38, Iss. 7, pp. 2383-2391
Open Access | Times Cited: 10
Modifiable risk factors for multiple sclerosis have consistent directions of effect across diverse ethnic backgrounds: a nested case–control study in an English population-based cohort
Benjamin Meir Jacobs, Pooja Tank, Jonathan P. Bestwick, et al.
Journal of Neurology (2023) Vol. 271, Iss. 1, pp. 241-253
Open Access | Times Cited: 10
Hormonal contraception methods and multiple sclerosis
N. Yu. Lashch, A. A. Ashikhmina, M.I. Kislaya, et al.
S S Korsakov Journal of Neurology and Psychiatry (2025) Vol. 125, Iss. 1, pp. 24-24
Closed Access
Designing and incorporating a real world data approach to international drug development and use: what the UK offers
Andrew Bate, Jane Juniper, Andy Lawton, et al.
Drug Discovery Today (2015) Vol. 21, Iss. 3, pp. 400-405
Open Access | Times Cited: 33
Contraceptive use among women with multiple sclerosis: a systematic review
Lauren B. Zapata, Titilope Oduyebo, Maura K. Whiteman, et al.
Contraception (2016) Vol. 94, Iss. 6, pp. 612-620
Open Access | Times Cited: 29
Autoimmune Diseases and Cardiovascular Risk: Mendelian Randomization Analysis for the Impact of 19 Autoimmune Diseases on 14 Cardiovascular Conditions
Yi Bao, Luo Gu, Jiayi Chen, et al.
Journal of Translational Autoimmunity (2024) Vol. 9, pp. 100259-100259
Open Access | Times Cited: 3
Aspirin and multiple sclerosis
Sheila Tsau, Mitchell R. Emerson, Sharon Lynch, et al.
BMC Medicine (2015) Vol. 13, Iss. 1
Open Access | Times Cited: 25
Thrombosis in Autoimmune Diseases: A Role for Immunosuppressive Treatments?
Antonella Scalera, Giacomo Emmi, Danilo Squatrito, et al.
Seminars in Thrombosis and Hemostasis (2016) Vol. 42, Iss. 06, pp. 650-661
Open Access | Times Cited: 25
Depressive Symptoms as a Novel Risk Factor for Recurrent Venous Thromboembolism: A Longitudinal Observational Study in Patients Referred for Thrombophilia Investigation
Roland von Känel, Angelina Margani, Stefanie Stauber, et al.
PLoS ONE (2015) Vol. 10, Iss. 5, pp. e0125858-e0125858
Open Access | Times Cited: 22
Vascular Disease in Patients with Multiple Sclerosis: A Review
Caprio MG, Camilla Russo
Journal of Vascular Medicine & Surgery (2016) Vol. 04, Iss. 02
Open Access | Times Cited: 21
The association between IgG and IgM antibodies against cardiolipin, β2-glycoprotein I and Domain I of β2-glycoprotein I with disease profile in patients with multiple sclerosis
Natalia Filippidou, George Krashias, Charis Pericleous, et al.
Molecular Immunology (2016) Vol. 75, pp. 161-167
Open Access | Times Cited: 17
Increased Pro-Thrombotic Platelet Activity Associated with Thrombin/PAR1-Dependent Pathway Disorder in Patients with Secondary Progressive Multiple Sclerosis
Angela Dziedzic, Elżbieta Miller, Michał Bijak, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7722-7722
Open Access | Times Cited: 16
Risk of Recurrent Venous Thromboembolism in Autoimmune Diseases: A Systematic Review of the Literature
Karina de Leeuw, Abraham Rutgers, Karina Meijer, et al.
Seminars in Thrombosis and Hemostasis (2018) Vol. 45, Iss. 02, pp. 141-149
Open Access | Times Cited: 16
Multiple sclerosis and the risk of systemic venous thrombosis: A systematic review
Omnya Ahmed, Ruth Geraldes, Gabriele C. DeLuca, et al.
Multiple Sclerosis and Related Disorders (2018) Vol. 27, pp. 424-430
Closed Access | Times Cited: 16
Page 1 - Next Page

Scroll to top